Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
ULTIBRO BREEZHALER 110/50 is indicated for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.
Pharmacology:
Contains indacaterol (a long-acting beta2-agonist) and glycopyrronium (a long-acting muscarinic antagonist). Together they relax airway muscles, improving airflow and reducing symptoms.
Dosage:
One capsule inhaled once daily using the Breezhaler device. Follow physician’s instructions precisely.
Administration:
Use the Breezhaler inhaler device to inhale the powder from the capsule. Do not swallow the capsule.
Interaction:
May interact with beta-blockers, anticholinergics, and other respiratory medicines. Inform your healthcare provider about all medications.
Contraindications:
Contraindicated in patients with hypersensitivity to indacaterol, glycopyrronium, or any component of the formulation.
Side Effects:
Common side effects include dry mouth, cough, headache, and throat irritation.
Pregnancy & Lactation:
Use only if clearly needed and prescribed by a doctor during pregnancy or breastfeeding.
Precautions & Warnings:
-
Not for acute bronchospasm relief.
-
Use with caution in patients with cardiovascular disorders.
-
Avoid exposure to allergens or triggers worsening COPD.
Therapeutic Class:
Bronchodilator (LABA + LAMA Combination)
Storage Conditions:
Store capsules below 30°C in a dry place, protected from moisture and light. Keep out of reach of children.
Change Language